🔍 RecallPedia

Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.

Class I - Dangerous
💊 Drugs Recalled: March 9, 2021 Cardinal Health Prescription Drugs

What Should You Do?

  1. Check if you have this product:
    KESOY.AI Exp. 04/2022
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Cardinal Health Inc.
Reason for Recall:
Temperature Abuse
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.

Product Codes/Lot Numbers:

KESOY.AI Exp. 04/2022

Distribution:

Distributed in: AL, LA, MS, TN

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0314-2021

Related Recalls